Trial Profile
A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Voglibose (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 22 Apr 2009 Results published in The Lancet
- 22 Apr 2009 Status changed from active, no longer recruiting to completed, according to results published in The Lancet.
- 22 Apr 2009 Results published in The Lancet